Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol

X Solanich, A Antolí, N Padullés, M Fanlo-Maresma, A Iriarte, F Mitjavila, O Capdevila, M Molina, J Sabater, J Bas, A Mensa-Vilaró, J Niubó, N Calvo, S Bolivar, R Rigo-Bonnin, L Arregui, C Tebé, P Hereu, S Videla, X Corbella
doi: https://doi.org/10.1101/2021.01.09.21249263

Data Availability

All data referred to the manuscript are available upon request to the corresponding author

Back to top
Posted January 12, 2021.
Download PDF
Data/Code
Email
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
X Solanich, A Antolí, N Padullés, M Fanlo-Maresma, A Iriarte, F Mitjavila, O Capdevila, M Molina, J Sabater, J Bas, A Mensa-Vilaró, J Niubó, N Calvo, S Bolivar, R Rigo-Bonnin, L Arregui, C Tebé, P Hereu, S Videla, X Corbella
medRxiv 2021.01.09.21249263; doi: https://doi.org/10.1101/2021.01.09.21249263
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area